News
Medtronic Stock Is a Sell, According to 1 Wall Street Analyst
One week ago, medical device maker Medtronic (NYSE: MDT) surpassed Wall Street's sales and earnings targets. Despite the earnings beat, and despite giving guidance that mostly matched analysts'
Hot IPO Viking Is a Fjord Tough Stock
May has been an adventurous month for Viking (NYSE: VIK). The world's leading operator of river cruise sailings went public at $24 on May 1. On Wednesday, it delivered its first financial update as
Beat the Dow Jones With This Cash-Gushing Dividend Stock
Since its spinoff from Pfizer in 2013, animal healthcare behemoth Zoetis (NYSE: ZTS) has seen its cash from operations nearly quintuple as a stand-alone company. Powered by a diverse array of animal
This Pharma Stock Is Poised to Keep Outperforming the S&P 500
AstraZeneca (NASDAQ: AZN), recognized as the world's sixth-largest pharmaceutical entity by market capitalization, made a bold proclamation in May 2014. The company set an ambitious goal of
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
Successful investors think about the future by focusing on what the new opportunities might be. They also pay attention to threats that could emerge that might impact the stocks they own. Sometimes
3 Dividend Stocks to Double Up on Right Now
Sometimes, misperceptions can work in investors' favor. When others think the outlook for a stock isn't so great, you can win big if that view is overly pessimistic.
Several stocks that pay
If You'd Invested $5,000 in Super Micro Computer Stock 5 Years Ago, Here's How Much You'd Have Today
Super Micro Computer (NASDAQ: SMCI) isn't new to the tech industry. The maker of servers, workstations, and full rack scale solutions actually has been around for 30 years -- but growth just took
Marjorie Taylor Greene Just Loaded Up on Stocks: Here Are the 6 She Bought
Sometimes politicians seem to have an uncanny ability to beat the market. In recognition of this, many investors outside of the Beltway pay particular attention to the trades of our senators and
EQS-News: Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock
As two of the world's largest and most prolific drugmakers, Pfizer (NYSE: PFE) and AstraZeneca (NASDAQ: AZN) both have grand visions for how to grow even larger over the coming years. And with
Where Will Amgen Be in 3 Years?
If you're looking for an investment in the pharmaceutical sector and you don't already own shares of Amgen (NASDAQ: AMGN), it might be worth considering a purchase. The company's development of
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock?
AstraZeneca (NASDAQ: AZN) is embarking on a fresh business plan that will see it grow significantly between now and 2030. If it succeeds, it'll be a company that's even more prominent in the global
3 High-Yield Dividend Stocks to Buy Hand Over Fist
If you're looking for dividend-paying companies that can help you earn more passive income, you've come to the right place. Here are three high-yield dividend stocks that are smart buys today.
For
Why Summit Therapeutics Stock Is Sinking Today
Shares of Summit Therapeutics (NASDAQ: SMMT) were sinking 22.6% as of 11:10 a.m. ET on Tuesday. This sell-off follows a similar steep decline of 22% on Friday after Summit revealed late-stage data
2 Beaten-Down Dividend Stocks Near 52-Week Lows. Should You Buy the Dips?
Does the stock market feel overbought to you? After watching the benchmark S&P 500 index climb about 28% over the past year, nobody can blame value-conscious investors for thinking twice before
EQS-News: Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease
2 Growth Stocks With Great Potential in 2024 and Beyond
A great way to position for success in the stock market is to look for companies that not only have great long-term prospects but, importantly, have catalysts in the near term that can send their
AEVIS VICTORIA SA – Ordinary General Meeting of Shareholders: all proposals approved
EQS-News: Gerresheimer expands capacities for Medical Systems in the USA
Got $500? 3 Pharma Stocks to Buy and Hold Forever
A sum of $500 might not seem like much of an investment, but if you select the right pharmaceutical stocks -- and are patient enough to hold them forever -- history shows you'll have a very high
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Vertex Pharmaceuticals (NASDAQ: VRTX) is a fast-growing pharmaceutical company that investors have been bullish on for years. The business generates billions in revenue from cystic fibrosis drugs
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow
As its shareholders already know, CRISPR Therapeutics (NASDAQ: CRSP) has quite a few opportunities on the table. Between its commercialized medicine, a pipeline that's packed with chances to mint
If You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have Today
Viking Therapeutics (NASDAQ: VKTX) stock is soaring. Two years ago, the share price hovered just above $2. Today, shares trade around $62. At Friday's prices, a paltry $100 investment in 2022 would
The Best Dividend Stocks to Buy Right Now
Dividend stocks can be boring, especially when AI-fueled stock gains are proliferating. Still, for long-term investors, buying sustainable dividend stocks with solid growth potential is a timeless
Forget Nvidia, Buy This Magnificent Healthcare Stock Instead
Nvidia (NASDAQ: NVDA) has been a great stock to own, and it could remain that way for long-term investors. However, the problem is that it's trading at nearly 40 times its future profits. At such a